Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q36174146

about

High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol Acute lymphoblastic leukaemia New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia Genetic abnormalities associated with acute lymphoblastic leukemia Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities Translating cancer genomes and transcriptomes for precision oncology JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications Diagnosis and subclassification of acute lymphoblastic leukemia Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia Childhood acute lymphoblastic leukemia: Integrating genomics into therapy Prognostification of ALL by Cytogenetics Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration 12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia CONSERTING: integrating copy-number analysis with structural-variation detection.Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study Spaced Seed Data Structures for De Novo Assembly.MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping.Solving the genetic puzzle of systemic lupus erythematosus.Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Childhood B-acute lymphoblastic leukemia: a genetic update.Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.

P2860

Q23749304-E3346A3B-7A58-4944-BFFF-D71255522B9B Q24602387-E8877DA8-04CB-4CF4-96BA-651CACB32893 Q26749177-979F8CEB-B310-4077-B07C-6E9393121EA3 Q26753823-82F7621B-AD4C-4273-9098-13C109401275 Q26768158-F08C2396-9E4C-4991-8D5B-4FD932252196 Q26777081-20606E02-1945-4F00-9C95-CE6B5AF75786 Q26782539-632BBBC5-8905-4EB8-8C00-63E7B7391973 Q26824387-4DF7E624-1D44-4489-A8A6-356A8918637A Q26864460-862A9D75-AEB4-452A-B829-D9CA260125E1 Q26866379-C6A9BE88-5838-445A-9984-59362BEA4A09 Q27025242-D4FFBF91-E266-4CF1-9279-0AA0E12F62DB Q27853366-F0E352C7-CD48-4030-B0B4-5358D407662E Q27853385-45CCEEA7-7FDA-4F5D-BDF2-DFCAF21C134E Q28080463-A562C42D-CCFB-40C8-AF18-2631EDB8551E Q28087446-5563FDBD-45AD-4FE6-8C74-AE531FEBE790 Q28087637-7EC3465B-A1B1-4573-AEF1-B092B9D8DACF Q28242134-137825D4-4AC0-4B77-831A-4A6ED4829B87 Q28274115-F3E2C4A5-64BF-4029-AF5D-7FE087059F2B Q28276513-689164F8-2FDD-43B0-9CE1-83C649B46CE2 Q28390558-499ACC94-1617-434F-BABA-77A10265FD61 Q28396029-01E20770-25B8-4C2C-9DF9-D9EBCB4061EB Q28541556-40C26B6F-B2FC-4F5B-92AF-A7D43919EF91 Q30397544-60035DB2-D13B-4112-BF51-9E91B1FB2E12 Q30666276-ABA7875B-1507-46DB-AAE9-D11C545A4909 Q30842603-8B4D83B7-B76C-420B-B701-4681A3252ED6 Q31018280-029EF503-4743-44FE-BEFA-6510D82F7E03 Q31153287-29EEAEF3-D0E0-446E-A7FA-A12905BD43D7 Q33359121-D21BADD3-1D52-4578-9268-16B062C395D9 Q33422654-DE9F9BE9-0AEF-4591-958B-FEE26ED094B5 Q33573735-4031BBD7-B3F3-46A8-9C83-AF00B945B328 Q33578333-5C0CD89F-F3B8-450A-A4F5-5EC7FB884709 Q33586588-EA0786CC-B843-4830-8FDA-1C1E4B9A6710 Q33622598-103F07D3-B040-46B6-8ACE-2F1C7B8AD2ED Q33688248-E7949FEF-D985-4319-8EB7-EEDD05FA5FDE Q33695967-947DB283-3D87-4F23-835D-7D103A38251F Q33711119-4FC0E116-5893-4AF7-A7C6-CE277836EFA4 Q33728277-DCBB71CD-9F87-4A9E-B9E8-3126B931C0BC Q33762835-86F15D9B-1DE7-465D-9294-58E8F67F9422 Q33777616-7BAA6C13-AD56-45BD-ADFA-C569DD815D2B Q33789597-B7B49138-2B46-41C7-BBE5-119B5EAB2388

P2860

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q36174146

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Genetic alterations activating ...... acute lymphoblastic leukemia.

@ast

Genetic alterations activating ...... acute lymphoblastic leukemia.

@en

type

label

Genetic alterations activating ...... acute lymphoblastic leukemia.

@ast

Genetic alterations activating ...... acute lymphoblastic leukemia.

@en

prefLabel

Genetic alterations activating ...... acute lymphoblastic leukemia.

@ast

Genetic alterations activating ...... acute lymphoblastic leukemia.

@en

P1433

Q36174146-81EBDECE-B3F6-4726-907E-31AC4C3752F3

P1476

Q36174146-5E55B26D-D1F7-4F55-8898-74AFDF238DDB

P2093

Q36174146-0052F356-21B6-46EB-A29C-647C5AC87939

Q36174146-1087B9B3-C325-4E72-85B9-DFB163E2C6E4

Q36174146-1452BFE1-5580-418E-A6EC-3C7785F029AF

Q36174146-157CEE91-FE6C-4050-8229-D69CA5B6875A

Q36174146-18273819-398F-4D60-AEC4-9CF3DAD4DE20

Q36174146-1D04E0DA-473A-47A9-8B9B-EB5ACFFF7E70

Q36174146-1F014014-3807-461D-B956-926B121A98CF

Q36174146-1F40E825-3E7F-4671-8E5B-D1614453515A

Q36174146-25D97175-D94A-4F2A-965D-8F0B1954062A

Q36174146-2ADCC4E8-E47F-4B49-9047-FD8D11D789F6

P2860

Q36174146-0425686B-B6AC-42CA-8302-175775B1898B

Q36174146-049A85B0-5586-44DD-BE89-3B32EAE836DE

Q36174146-057B1958-53EE-4B47-8B77-80DF656A2E53

Q36174146-0689CAE9-9B17-48A6-89B6-7A902E531179

Q36174146-080F95C8-9CE6-4601-AEBD-AD514ABA1604

Q36174146-0B23FCEB-ACC0-47D5-B8FB-CAB4202A2336

Q36174146-0BF4D138-CC44-46F0-991C-0CA0AF935A29

Q36174146-0E461270-9FE9-481D-9211-382F78F8F55C

Q36174146-103FD678-801B-4992-871F-9D5DABB7D5B7

Q36174146-196E53C0-09EE-4333-B52F-79C14355A2D2

P304

Q36174146-27D19F2D-77B0-4B02-9FE8-CEF7ECC0ABC5

P31

Q36174146-818C02B9-1DB9-420C-8F7B-8891F17553FB

P356

Q36174146-334C5F2E-D7FB-4EF3-ADA5-BD270DC501CC

P433

Q36174146-85F667A8-A01B-4FA5-B3A0-7E3B92359C82

P478

Q36174146-9EB70099-6884-4FB9-9F54-F4EFFC9109BC

P50

Q36174146-27E2188E-0E36-4A84-89A1-587E2931D7F4

Q36174146-3098FC39-6D25-479B-8C38-308E151E8C82

Q36174146-768463C6-DE1F-49D1-8C1D-7C001D7B1998

Q36174146-AC877619-A6FB-4727-9505-6496474E0505

Q36174146-D359D01A-B877-4E5B-AFAB-B29926E3C3E0

Q36174146-E0BB03F7-A380-4685-964C-D697416EDFFE

Q36174146-EB69D26C-3600-4A21-9CC6-CCCC1B95E126

Q36174146-F287CB8B-8ACD-424F-A141-A0B3959B8E19

P577

Q36174146-C4947852-4950-4D2B-AD26-115BB11589B1

P5875

Q36174146-D529B122-01D7-405C-8025-5B69AAE18FE4

P698

Q36174146-825773A6-84B8-4FDF-ADA5-0933AB24E6C8

P921

Q36174146-DADDAEB1-02E3-49C4-9279-E152CFEF130A

P932

Q36174146-66E2727E-DD62-4129-9504-CDFE2B65655E

P356

J.CCR.2012.06.005

P1433

P1476

Genetic alterations activating ...... acute lymphoblastic leukemia.

@en

P2093

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Chunhua Yan

http://www.w3.org/2001/XMLSchema#string

Corynn Kasap

http://www.w3.org/2001/XMLSchema#string

Daniela S Gerhard

http://www.w3.org/2001/XMLSchema#string

David T Teachey

http://www.w3.org/2001/XMLSchema#string

Debbie Payne-Turner

http://www.w3.org/2001/XMLSchema#string

Eric Larsen

http://www.w3.org/2001/XMLSchema#string

Gregory Reaman

http://www.w3.org/2001/XMLSchema#string

Guillermo Garcia-Manero

http://www.w3.org/2001/XMLSchema#string

I-Ming Chen

http://www.w3.org/2001/XMLSchema#string

P2860

EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Treating childhood acute lymphoblastic leukemia without cranial irradiation

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Diagnosis of multiple cancer types by shrunken centroids of gene expression

P304

153-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2012.06.005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Charles G. Mullighan

Richard C Harvey

Malcolm A Smith

Stephen P Hunger

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230684437

http://www.w3.org/2001/XMLSchema#string

P698

22897847

http://www.w3.org/2001/XMLSchema#string

P921

P932

3422513

http://www.w3.org/2001/XMLSchema#string